Key result
BodyGuard2 yields highly consistent HRV indices compared with standard ECG in young children.
Why the study?
Testing the reliability of ambulatory cardiac devices on children compared to gold-standard laboratory devices is rarely conducted.
Observational
There has been an increasing interest in using cardiac indicators of self-regulation in developmental science. Many researchers are interested in unobtrusive mobile devises that are able to collect reliable cardiac data outside of the laboratory setting. Although numerous new ambulatory devices have become available over the last decade, testing these devices on children in comparison to industry gold-standard devices is rarely conducted. The current study evaluated the reliability of one of these ambulatory systems, the BodyGuard2 (FirstBeat), relative to gold-standard laboratory electrocardiogram (Biopac MP150), during active and resting conditions in 4- to 6-year-old children. The BodyGuard2 performed and produced highly similar indices of heart rate variability across resting and active conditions.
No takes yet. Share an insight, caveat, or question.
Palmer et al. (2021) reported an observational. BodyGuard2 (FirstBeat) vs. laboratory electrocardiogram (Biopac MP150) was evaluated on reliability of heart rate variability indices during active and resting conditions. The BodyGuard2 produced highly similar indices of heart rate variability relative to gold-standard laboratory electrocardiogram during active and resting conditions in 4- to 6-year-old children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: